Flow cytometric analysis of tumor-infiltrating T cells further revealed that apart from increasing total CD8+ T cells, combining application of Tnks1bp1 knockdown and anti-PD-L1 treatment could also significantly decrease PD-1+ CD8+ T cells (Fig. 7L; Fig. S8). Here, PDCD1 is linked to neoplasm.